alclometasone
Regulatory sources consulted
Approved indications
- Relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Contraindications
Absolute
- Hypersensitivity to alclometasone or any component.
Clinical warnings
- Major warning · Use the smallest effective amount for the shortest possible time. Large areas, prolonged use, an impaired skin barrier, and occlusion increase absorption and may cause reversible HPA-axis suppression, Cushing syndrome, hyperglycemia, or glucosuria; children are more susceptible. — DailyMed/openFDA, SPL set ID 3b0dccd6-dee1-49dd-8c6d-82df5c7ee36c
- Avoid eye contact. Stop if irritation or sensitization occurs. Treat any skin infection; if it does not respond promptly, stop the corticosteroid until it is controlled. — DailyMed/openFDA, SPL set ID 3b0dccd6-dee1-49dd-8c6d-82df5c7ee36c
Adverse events
Common (≥1%)
Local itching, burning, or erythema
Pregnancy and lactation
During pregnancy, use only if potential benefit justifies risk and avoid extensive amounts or prolonged periods. Use cautiously during breastfeeding.